GeneDx is a genomics company specializing in advanced genetic testing services to diagnose rare and complex diseases. With over 25 years of expertise and nearly one million exomes and genomes sequenced, GeneDx offers comprehensive solutions that provide precise, fast, and actionable insights for patients and healthcare providers.
Key Features and Functionality:
- Whole Exome Sequencing (ExomeDx™): Targets approximately 20,000 protein-coding genes, identifying pathogenic variants associated with various conditions.
- Whole Genome Sequencing (GenomeDx™): Provides a complete analysis of an individual's DNA, detecting variants across coding and non-coding regions, including structural changes often missed by other methods.
- Rapid Testing Options: Offers expedited testing with results available in as soon as 5 days for critical cases, facilitating timely diagnosis and treatment decisions.
- Non-Invasive Sample Collection: Utilizes buccal (cheek swab) samples, making the testing process accessible and comfortable for patients of all ages.
- GeneDx Infinity™ Dataset: Leverages one of the largest rare disease datasets, encompassing over 2.5 million tests and more than 7 million phenotypic data points, enhancing diagnostic accuracy and supporting the discovery of new treatments.
Primary Value and Solutions:
GeneDx addresses the challenges of diagnosing rare and complex conditions by delivering comprehensive genetic testing that leads to faster and more accurate diagnoses. This approach reduces the typical diagnostic odyssey, which can take years, thereby enabling earlier interventions and personalized treatment plans. By integrating extensive genomic data with advanced interpretation tools, GeneDx empowers healthcare providers to make informed decisions, ultimately improving patient outcomes and advancing the field of precision medicine.
